Shukra Pharmaceuticals Board Meeting on Aug 22 to Approve AGM

Shukra Pharmaceuticals Ltd has announced a Board of Directors meeting scheduled for August 22, 2026. The primary agenda items include considering and approving a change in the company's name and object clause, subject to shareholder approval. The board will also approve the draft notice for a postal ballot to seek member consent for these changes, appoint a scrutinizer for the postal ballot, and approve the draft Director's Report and Secretarial Audit Report for the fiscal year ended March 31, 2026. Additionally, the meeting will fix the date, time, and venue for the Annual General Meeting (AGM), decide on book closure dates, and appoint a scrutinizer for remote e-voting and the AGM. The trading window for designated employees will be closed from August 17 to August 24, 2026.